FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085195775> ?p ?o ?g. }

• W2085195775 endingPage "494" @default.
• W2085195775 startingPage "489" @default.
• W2085195775 abstract "Background and Purpose —We chose to evaluate the safety and efficacy of combined intrathrombus rtPA and intravenous heparin in cerebral venous thrombosis (CVT). Methods —We treated 12 patients with symptoms of 1 to 40 days’ duration (eg, headache, somnolence, focal deficits, seizures, and nausea and vomiting). Pretreatment MRI disclosed subtle hemorrhagic venous infarction in 4 patients, obvious hemorrhagic infarction in 2, small parenchymal hemorrhage from recent pallidotomy in 1, and no focal lesion in 5. Magnetic resonance venography and contrast venography identified thrombi in the superior sagittal sinus (SSS) in 3 patients; transverse/sigmoid sinus (TS/SS) in 2; SSS and both TS/SS in 1; SSS and 1 TS/SS in 5; and SSS, 1 TS/SS, and straight sinus in 1 patient. A loading dose of rtPA was instilled throughout the clot at 1 mg/cm, followed by continuous intrathrombus infusion at 1 to 2 mg/h. Intravenous heparin was infused concomitantly. Results —Flow was restored completely in 6 patients and partially in 3, with a mean rtPA dose of 46 mg (range, 23 to 128 mg) at a mean time of 29 hours (range, 13 to 77 hours). Symptoms improved in these 9 patients concomitantly with flow restoration. Flow could not be restored in 3 patients. In 1 of them, treatment was stopped when little progress had been made, and fibrinogen level dropped to 118 mg/dL. In the other 2 patients, hemorrhagic worsening occurred, and treatment was abbreviated after initial rtPA dosing. In 1 of these, the hematoma was evacuated. Conclusions —Our experience with intrathrombus rtPA in conjunction with intravenous heparin in patients with CVT is encouraging. This therapy should probably be regarded as unsafe in patients with obvious hemorrhage. Time to restore flow may be faster than with urokinase (an average of 71 hours has been reported for 29 documented patients). Further evaluation of rtPA with heparin in CVT is warranted." @default.
• W2085195775 created "2016-06-24" @default.
• W2085195775 creator A5018525276 @default.
• W2085195775 creator A5022788776 @default.
• W2085195775 creator A5059796249 @default.
• W2085195775 creator A5079514507 @default.
• W2085195775 creator A5083629600 @default.
• W2085195775 date "1999-03-01" @default.
• W2085195775 modified "2023-10-16" @default.
• W2085195775 title "Cerebral Venous Thrombosis" @default.
• W2085195775 cites W1562188698 @default.
• W2085195775 cites W1822060035 @default.
• W2085195775 cites W1970850143 @default.
• W2085195775 cites W1993300947 @default.
• W2085195775 cites W2033831494 @default.
• W2085195775 cites W2034260027 @default.
• W2085195775 cites W2037326148 @default.
• W2085195775 cites W2041113836 @default.
• W2085195775 cites W2052451961 @default.
• W2085195775 cites W2081695773 @default.
• W2085195775 cites W2081714383 @default.
• W2085195775 cites W2086407730 @default.
• W2085195775 cites W2088284151 @default.
• W2085195775 cites W2096106732 @default.
• W2085195775 cites W2117560232 @default.
• W2085195775 cites W2122333876 @default.
• W2085195775 cites W2128730599 @default.
• W2085195775 cites W2134850936 @default.
• W2085195775 cites W2146241859 @default.
• W2085195775 cites W2161798056 @default.
• W2085195775 cites W2412985522 @default.
• W2085195775 cites W4254273684 @default.
• W2085195775 cites W45221573 @default.
• W2085195775 doi "https://doi.org/10.1161/01.str.30.3.489" @default.
• W2085195775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10066841" @default.
• W2085195775 hasPublicationYear "1999" @default.
• W2085195775 type Work @default.
• W2085195775 sameAs 2085195775 @default.
• W2085195775 citedByCount "212" @default.
• W2085195775 countsByYear W20851957752012 @default.
• W2085195775 countsByYear W20851957752013 @default.
• W2085195775 countsByYear W20851957752014 @default.
• W2085195775 countsByYear W20851957752015 @default.
• W2085195775 countsByYear W20851957752016 @default.
• W2085195775 countsByYear W20851957752017 @default.
• W2085195775 countsByYear W20851957752018 @default.
• W2085195775 countsByYear W20851957752019 @default.
• W2085195775 countsByYear W20851957752020 @default.
• W2085195775 countsByYear W20851957752021 @default.
• W2085195775 countsByYear W20851957752022 @default.
• W2085195775 crossrefType "journal-article" @default.
• W2085195775 hasAuthorship W2085195775A5018525276 @default.
• W2085195775 hasAuthorship W2085195775A5022788776 @default.
• W2085195775 hasAuthorship W2085195775A5059796249 @default.
• W2085195775 hasAuthorship W2085195775A5079514507 @default.
• W2085195775 hasAuthorship W2085195775A5083629600 @default.
• W2085195775 hasBestOaLocation W20851957751 @default.
• W2085195775 hasConcept C126322002 @default.
• W2085195775 hasConcept C141071460 @default.
• W2085195775 hasConcept C148699463 @default.
• W2085195775 hasConcept C197934379 @default.
• W2085195775 hasConcept C2776394524 @default.
• W2085195775 hasConcept C2776620988 @default.
• W2085195775 hasConcept C2778269268 @default.
• W2085195775 hasConcept C2778379562 @default.
• W2085195775 hasConcept C2779034229 @default.
• W2085195775 hasConcept C2779662492 @default.
• W2085195775 hasConcept C2780011451 @default.
• W2085195775 hasConcept C2780580376 @default.
• W2085195775 hasConcept C2780852908 @default.
• W2085195775 hasConcept C2780868729 @default.
• W2085195775 hasConcept C42219234 @default.
• W2085195775 hasConcept C71924100 @default.
• W2085195775 hasConceptScore W2085195775C126322002 @default.
• W2085195775 hasConceptScore W2085195775C141071460 @default.
• W2085195775 hasConceptScore W2085195775C148699463 @default.
• W2085195775 hasConceptScore W2085195775C197934379 @default.
• W2085195775 hasConceptScore W2085195775C2776394524 @default.
• W2085195775 hasConceptScore W2085195775C2776620988 @default.
• W2085195775 hasConceptScore W2085195775C2778269268 @default.
• W2085195775 hasConceptScore W2085195775C2778379562 @default.
• W2085195775 hasConceptScore W2085195775C2779034229 @default.
• W2085195775 hasConceptScore W2085195775C2779662492 @default.
• W2085195775 hasConceptScore W2085195775C2780011451 @default.
• W2085195775 hasConceptScore W2085195775C2780580376 @default.
• W2085195775 hasConceptScore W2085195775C2780852908 @default.
• W2085195775 hasConceptScore W2085195775C2780868729 @default.
• W2085195775 hasConceptScore W2085195775C42219234 @default.
• W2085195775 hasConceptScore W2085195775C71924100 @default.
• W2085195775 hasIssue "3" @default.
• W2085195775 hasLocation W20851957751 @default.
• W2085195775 hasLocation W20851957752 @default.
• W2085195775 hasOpenAccess W2085195775 @default.
• W2085195775 hasPrimaryLocation W20851957751 @default.
• W2085195775 hasRelatedWork W2089712240 @default.
• W2085195775 hasRelatedWork W2145304738 @default.
• W2085195775 hasRelatedWork W2347586948 @default.
• W2085195775 hasRelatedWork W2350960539 @default.

• next